CAR T-Cell Therapy
Cell therapy in which a patient's or donor's T cells are engineered with a synthetic receptor that recognises a selected disease antigen.
A living academic reference written, refined and transparently versioned by the Sciendia community.
Collaborative knowledgeSearch
8 results
Wiki pages are public to read. Every signed-in member can create and improve them.
Clear searchCell therapy in which a patient's or donor's T cells are engineered with a synthetic receptor that recognises a selected disease antigen.
Analysis of tumour-derived DNA, cells, vesicles or other biomarkers in blood and body fluids to characterise cancer non-invasively.
The reciprocal control between cellular metabolic pathways and the activation, differentiation and function of immune cells.
Medicines that deliver engineered messenger RNA so cells transiently produce a therapeutic protein or antigen.
Methods that measure gene expression while preserving the locations and neighbourhoods of cells within tissue.
Treatments that redirect, strengthen or release immune responses to recognise and control malignant cells.
Methods that measure transcript abundance in individual cells to resolve heterogeneous biological populations.
A programmable molecular system that can cut DNA near a sequence selected by a guide RNA.